Covestor Ltd - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 169 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Covestor Ltd ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$0–50.0%0.00%–
Q2 2023$0–50.0%0.00%–
Q1 2023$0–5
-50.0%
0.00%–
Q4 2022$0–10
+100.0%
0.00%–
Q3 2022$0–5
-16.7%
0.00%–
Q2 2022$0–6
-25.0%
0.00%–
Q1 2022$0–8
-20.0%
0.00%–
Q4 2021$0–10–0.00%–
 Download
Other shareholders

There were no reported owners of CELLDEX THERAPEUTICS INC NEW in Q1 2022.

NameSharesValueWeighting ↓
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders